Patents Examined by Marjan Fardanesh
  • Patent number: 11737688
    Abstract: Apparatus and methods are operative to probe the condition of a sensor either initially, at any point thereafter or continuously during a continuous sensor operation for measuring an analyte in a bodily fluid (such as performed by, e.g., a continuous glucose monitoring (CGM) sensor). Results of the probe may include calibration indices determined from electrical signals obtained during the probe. The calibration indices may indicate whether in-situ adjustment of the sensor's calibration should be performed either initially and/or at random check points. Probing potential modulation parameters also may be used during analyte calculations to reduce the effects of lot-to-lot sensitivity variations, sensitivity drift during monitoring, temperature, interferents, and/or the like. Other aspects are disclosed.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: August 29, 2023
    Assignee: Ascensia Diabetes Care Holdings AG
    Inventors: Huan-Ping Wu, Mark D. Cerutti
  • Patent number: 11730404
    Abstract: Implantable device for measuring the glucose concentration of a body fluid when implanted, the device comprising a glucose measurement unit, the glucose measurement unit comprising a light source configured to emit light towards a light transmissive part of a housing of the device, the device further comprising an optical sensor configured to detect light returned through the transmissive part from the light source, and output an electrical signal based on the detected light, and a wireless communication module configured to wirelessly communicate with an external wireless communication device, wherein the wireless communication module is configured to wirelessly transmit a signal based on the electrical signal to the external wireless communication device.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: August 22, 2023
    Assignee: Sanofi
    Inventor: Thomas Klemm
  • Patent number: 11730375
    Abstract: A photoacoustic, noninvasive, and continuous blood glucose measurement device includes: a diode laser for irradiating a living body with a pulsed laser signal having a specific wavelength; and an ultrasound transducer for measuring a photoacoustic signal in a form of ultrasonic waves generated by a reaction of the living body with the pulsed laser signal.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: August 22, 2023
    Assignees: HYUNDAI MOTOR COMPANY, KIA MOTORS CORPORATION, POSTECH ACADEMY-INDUSTRY FOUNDATION
    Inventors: Eung Hwan Kim, Seul Ki Jeon, Nam Woong Hur, Jin Woo Baik, Jin Young Kim, Da Yoon Kang, Chul Hong Kim
  • Patent number: 11701009
    Abstract: An apparatus for measuring bio-information may include: a pulse wave sensor comprising at least one pair of light emitters which are disposed apart from each other and a light receiver disposed between the at least one pair of light emitters, and configured to measure a plurality of pulse wave signals from an object by using the light receiver and the at least one pair of light emitters; a force sensor configured to measure a contact force that is applied to the pulse wave sensor by the object; and a processor configured to generate an integrated pulse wave signal by integrating the plurality of pulse wave signals based on the contact force and an area of a contact surface of the pulse wave sensor, and estimate bio-information of the object based on the integrated pulse wave signal.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: July 18, 2023
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Jeong Eun Hwang, Byung Hoon Ko, Chang Mok Choi, Sang Yun Park, Jong Wook Lee
  • Patent number: 11690573
    Abstract: A system for a physiological characteristic sensor deployed with a sensor inserter includes an adhesive skin patch coupled to the physiological characteristic sensor. The adhesive patch is to couple the physiological characteristic sensor to an anatomy. The system also includes a gravity resistance system coupled to the adhesive patch and to be coupled to the sensor inserter. The gravity resistance system maintains the adhesive patch substantially perpendicular to a longitudinal axis of the sensor inserter prior to deployment of the physiological characteristic sensor and is removable from the adhesive patch by the sensor inserter upon deployment of the physiological characteristic sensor.
    Type: Grant
    Filed: December 18, 2019
    Date of Patent: July 4, 2023
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Jasson Rodriguez, Ellis Garai, Ravi R. Deverkadra, Sara M. Voisin, Jacob E. Pananen
  • Patent number: 11684317
    Abstract: A disease prediction model construction apparatus is provided. The disease prediction model construction apparatus may include a spectral data acquisition unit that emits near-infrared rays toward a skin of a subject to acquire near-infrared spectral data and a prediction model construction unit that constructs a disease prediction model based on a time-blood glucose graph generated from the acquired near-infrared spectral data.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: June 27, 2023
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Eui Seok Shin, Jin Young Park, Seung Jun Lee
  • Patent number: 11672452
    Abstract: Described here are meters and methods for sampling, transporting, and/or analyzing a fluid sample. The meters may include a meter housing and a cartridge. In some instances, the meter may include a tower which may engage one or more portions of a cartridge. The meter housing may include an imaging system, which may or may not be included in the tower. The cartridge may include one or more sampling arrangements, which may be configured to collect a fluid sample from a sampling site. A sampling arrangement may include a skin-penetration member, a hub, and a quantification member.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: June 13, 2023
    Assignee: Intuity Medical, Inc.
    Inventors: Raul Escutia, Paul D. Reynolds, John F. Larkin, Charles Hu, Michael F. Tomasco, Daniel R. Bloom, Joseph A. Vivolo, Richard M. Wiard
  • Patent number: 11660028
    Abstract: Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: May 30, 2023
    Assignee: Masimo Corporation
    Inventors: Walter J. Shakespeare, William Henry Bennett, Jason T. Iceman, Howard P. Apple, Phillip William Wallace, Matthew J. Schurman
  • Patent number: 11660228
    Abstract: An obstructive sleep apnea detection device including an optical engagement surface adapted to engage a user's skin; a light source adapted to emit light from the optical engagement surface; a photodetector adapted to detect light at the optical engagement surface and to generate a detected light signal; a position sensor adapted to determine patient sleeping position; a controller adapted to determine and record in memory blood oxygen saturation values computed from the detected light signal and user position information from the position sensor; and a housing supporting the optical engagement surface, the photodetector, the light source, the position sensor, and the controller.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: May 30, 2023
    Assignee: Oura Health Oy
    Inventors: Thomas G. Goff, Kirby Chiang, Nathaniel L. Bowditch
  • Patent number: 11658514
    Abstract: This application describes a novel approach of wireless charging or powering of a sensor-based device used for in vivo diagnosis and monitoring. In addition to implantable or subcutaneous devices, this approach can also be used for wireless charging of wearable and handheld devices. Specifically, this application describes charging of diagnostic and monitoring devices used for disease detection and management. More specifically, this application describes a method to wirelessly power integrated devices designed to detect or monitor analytes (e.g. biological or chemical species) and release drugs into the body in response to a specific change in the body's vitals, detected by the device.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: May 23, 2023
    Assignee: FemtoDx, Inc.
    Inventors: Pritiraj Mohanty, Shyamsunder Erramilli
  • Patent number: 11653861
    Abstract: A method for determining oxygen saturation includes emitting light from sources into tissue; detecting the light by detectors subsequent to reflection; and generating reflectance data based on detecting the light. The method includes determining a first subset of simulated reflectance curves from a set of simulated reflectance curves stored in a tissue oximetry device for a coarse grid; and fitting the reflectance data points to the first subset of simulated reflectance curves to determine a closest fitting one of the simulated reflectance curves. The method includes determining a second subset of simulated reflectance curves for a fine grid based on the closest fitting one of the simulated reflectance curves; determining a peak of absorption and reflection coefficients from the fine grid; and determining an absorption and a reflectance coefficient for the reflectance data points by performing a weighted average of the absorption coefficients and reflection coefficients from the peak.
    Type: Grant
    Filed: February 9, 2021
    Date of Patent: May 23, 2023
    Assignee: ViOptix, Inc.
    Inventors: Kate LeeAnn Bechtel, H. Keith Nishihara
  • Patent number: 11627896
    Abstract: A method for calibrating detectors of a self-contained, tissue oximetry device includes emitting light from a light source into a tissue phantom, detecting in a plurality of detectors the light emitted from the light source, subsequent to reflection from the tissue phantom, and generating a set of detector responses by the plurality of detectors based on detecting the light emitted from the light source. The method further includes determining a set of differences between the set of detector responses and a reflectance curve for the tissue phantom, and generating a set of calibration functions based on the set of differences. Each calibration function in the set of calibration functions is associated with a unique, light source-detector pair. The method further includes storing the set of calibration function in a memory of the self-contained, tissue oximetry device.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: April 18, 2023
    Assignee: ViOptix, Inc.
    Inventors: Kate LeeAnn Bechtel, Brian Wilfley
  • Patent number: 11602288
    Abstract: Provided is a monitor for monitoring the condition of the interior of a living organism from the surface of the living organism. The monitor is provided with: a probe which includes an observation window and is attached to the organism surface; a unit which irradiates, with a laser, at least a portion of an observation region; a unit which detects scattered light resulting from the laser irradiation; a Doppler analysis unit and a SORS analysis unit which narrow down the observation spots to a first observation spot; and a CARS analysis unit which obtains the optical spectrum for at least one component, and outputs first information indicating the condition of the organism interior on the basis of the intensity of the spectrum.
    Type: Grant
    Filed: November 19, 2019
    Date of Patent: March 14, 2023
    Assignee: ATONARP INC.
    Inventor: Prakash Sreedhar Murthy
  • Patent number: 11574708
    Abstract: Aspects relate to a portable device that may be used to identify a critical intensity and an anaerobic work capacity of an individual. The device may utilize muscle oxygen sensor data, speed data, or power data. The device may utilize data from multiple exercise sessions, or may utilize data from a single exercise session. The device may additionally estimate a critical intensity from a previous race time input from a user.
    Type: Grant
    Filed: August 24, 2020
    Date of Patent: February 7, 2023
    Assignee: NIKE, Inc.
    Inventors: Brett S. Kirby, Bradley W. Wilkins, David Clark, Eric Bradley, Elizabeth Besemer
  • Patent number: 11553862
    Abstract: An electrode measuring the presence of an analyte is described as one embodiment. The electrode includes a working conductor with an electrode reactive surface and a first reactive chemistry that is responsive to the analyte. The electrode further includes a first transport material that enables flux of the first analyte to the first reactive chemistry and a second transport material that supplies a reactant to the first reactive chemistry. Wherein the first reactive chemistry does not contact the electrode reactive surface while at least partially shadowing a portion of the electrode reactive surface.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: January 17, 2023
    Assignee: PercuSense, Inc.
    Inventors: Rajiv Shah, Bradley Liang, Katherine Wolfe, Ellen Messer, Shaun Pendo
  • Patent number: 11547326
    Abstract: A biomarker diagnostic system includes a sensor to collect a sweat sample from a biological subject; a processor operatively connected to the sensor, wherein the processor is configured to perform metabolic and proteomic profiling of biomarkers in the sweat sample. The metabolic and proteomic profile is compared to a predetermined profile of the biomarkers and to determine a physiological status of the biomarkers. The system further includes a feedback unit operatively coupled to the sensor and the processor and configured to output physiological performance data based on the physiological status.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: January 10, 2023
    Assignee: United States of America as represented by the Secretary of the Air Force
    Inventors: Sean W. Harshman, Anthony V. Qualley, Nicole M. Schaeublin, Jennifer A. Martin, Claude C. Grigsby, Rhonda L. Pitsch
  • Patent number: 11529079
    Abstract: A method may include receiving, at a processor, a first electromagnetic radiation signal and a second electromagnetic radiation signal from a regional oximetry sensor having two or more detectors and two or more emitters. The method may also include receiving, at the processor, a trigger signal that has a frequency corresponding to a periodic physical activity of a patient. Additionally, the method may include generating, via the processor, one or more ensemble averaged signals based at least in part on the first and second electromagnetic radiation signals and the trigger signal. Further, the method may include calculating, via the processor, a regional oxygen saturation value based at least in part on the one or more ensemble averaged signals and displaying, via a display, the regional oxygen saturation value.
    Type: Grant
    Filed: May 22, 2019
    Date of Patent: December 20, 2022
    Assignee: COVIDIEN LP
    Inventor: Daniel Lisogurski
  • Patent number: 11529101
    Abstract: When evaluating the quality of photoplethysmography (PPG) signal (52) measured from a patient monitor (e.g., a finger sensor or the like), multiple features of the PPG signal are extracted and analyzed to facilitate assigning a score to the PPG signal or portions (e.g., heartbeats) thereof. Heartbeats in the PPG signal are segmented out using concurrently captured electrocardiograph (ECG) signal (50), and for each heartbeat, a plurality of extracted features are analyzed. If all extracted features satisfy one or more predetermined criteria for each feature, then the heartbeat waveform is compared to a predefined heartbeat template. If the waveform matches the template (e.g., within a predetermined match percentage or the like), then the heartbeat is classified as “clean.” If the heartbeat does not patch the template, or if one or more of the extracted features fails to satisfy its one or more pre-determined criteria, the heartbeat is classified as “noisy.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: December 20, 2022
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Erina Ghosh, Cristhian Mauricio Potes Blandon
  • Patent number: 11529066
    Abstract: Disclosed is an antenna device for measuring biometric information by using dark mode excitation. The antenna device according to an embodiment may include a conducting wire forming a loop. A current may be induced into the loop through an interaction with a magnetic field generated by an antenna connected to a power source. Information on an analyte may be sensed using a magnetic field formed based on the current induced into the loop.
    Type: Grant
    Filed: November 24, 2021
    Date of Patent: December 20, 2022
    Assignee: SB SOLUTIONS INC.
    Inventors: Seungup Seo, Namhwan Sung, Hae Dong Lee, Seong Mun Kim, Ji Woong Song, Jagannath Malik
  • Patent number: 11517222
    Abstract: A system and method for monitoring body chemistry of a user, the system comprising: a housing supporting: a microsensor comprising a first and second working electrode, a reference electrode, and a counter electrode, and configured to access interstitial fluid of the user, and an electronics subsystem comprising a signal conditioning module that receives a signal stream, from the microsensor, wherein the electronics subsystem is configured to detect an impedance signal derived from two of the first working electrode, the second working electrode, the reference electrode, and the counter electrode; and a processing subsystem comprising: a first module configured to generate an analysis indicative of an analyte parameter of the user and derived from the signal stream and the impedance signal, and a second module configured to transmit information derived from the analysis to the user, thereby facilitating monitoring of body chemistry of the user.
    Type: Grant
    Filed: May 23, 2022
    Date of Patent: December 6, 2022
    Assignee: One Drop Biosensor Technologies, LLC
    Inventors: Ashwin Pushpala, Dominic Pitera, Matthew Chapman, Michael Gifford